单球囊双侧扩张椎体后凸成形术的探讨

目的探讨单球囊双侧扩张椎体后凸成形术治疗老年骨质疏松性脊柱压缩骨折的临床疗效。方法2002年3月～2004年2月,采用单球囊双侧扩张椎体后凸成形术治疗老年骨质疏松性脊柱压缩骨折15例17椎,男6例6椎,女9例11椎;年龄62～83岁,平均70.5岁。T12 8椎,L1 7椎,T8 1椎,T11 1椎。术前CT显示椎体后壁均完整。MRI显示骨折椎体在T1WI呈低信号,T2WI呈高信号。经骨密度仪测定证实脊椎均存在不同程度的骨质疏松,平均骨密度为0.603g/cm2。结果所有患者术后疼痛均明显减轻,疼痛视觉模拟数字评分由术前平均8.3分降至术后平均2.1分。平均椎体前缘高度恢复54.2%±34.1%,中部恢复60.5%±35.4%,后缘恢复40.7%±32.3%。矢状面排列改善明显。手术前后侧位X线片示Cobb角平均改善9.5°(0°～28°)。平均灌注骨水泥5.9ml(3.5～7.8ml)。除1个椎体前缘有少许未引起临床症状的骨水泥渗漏外,其余椎体在X线片上均无明显骨水泥渗漏。所有患者均获得随访,随访时间2～48个月,平均10.5个月,未发现与手术有关的并发症出现。结论单球囊双侧扩张椎体后凸成形术治疗老年骨质疏松性脊柱压缩骨折可以有效缓解疼痛,恢复椎体高度,改善椎体矢状面排列,疗效满意。     

球囊扩张椎体后凸成形术治疗老年骨质疏松性椎体骨折

目的：探讨球囊扩张椎体后凸成形注入骨水泥治疗老年骨质疏松性椎体骨折的疗效。方法：对52例老年骨质疏松性单椎体骨折患者采用球囊扩张椎体后凸成形术治疗。在DSA透视引导下行单侧或双侧椎弓根穿刺,注入骨水泥。结果：发生骨水泥渗漏6例,术后1周腰背疼痛、后凸角度、伤椎高度、活动能力较术前明显改善（P〈0.05）,术后6个月、末次随访与术后1周,上述指标比较差异均无显著性（P〉0.05）。结论：球囊扩张椎体后凸成形注入骨水泥,不仅能够明显缓解骨质疏松性脊柱骨折导致的疼痛,而且可以部分恢复椎体高度和改善脊柱后凸畸形,有利于脊柱功能的恢复。     

椎体后凸成形术治疗老年骨质疏松脊柱压缩骨折

目的探讨球囊扩张椎体后凸成形术治疗老年骨质疏松脊柱压缩骨折的疗效和安全性。方法自2000年5月～2002年6月采用椎体后凸成形术(kyphoplasty)治疗老年骨质疏松脊柱压缩骨折30例56椎,均为椎体后壁完整的疼痛性骨质疏松脊柱压缩骨折。手术过程包括经双侧椎弓根或椎弓根旁置入两枚可扩张球囊使骨折塌陷椎体复位,以及用骨水泥充填由球囊扩张所形成的椎体内空腔。观察术后症状改善及骨折复位情况,分析并发症。结果30例患者手术均顺利完成,在术后48h内疼痛均明显缓解。骨折椎体前缘和中部高度的丢失分别由术前的(13.6±2.3)mm和(9.2±1.4)mm减至术后的(4.7±1.5)mm和(3.4±1.1)mm,后凸畸形Cobb角由术前的23.4°±5.2°矫正至术后的9.2°±4.7°。1例患者术后发现少量骨水泥渗漏至椎体侧方软组织内;1例1侧术中穿刺管内出现脑脊液,当即停止该侧手术。此2例患者均未出现临床症状。未出现其他严重并发症。结论球囊扩张椎体后凸成形术作为治疗疼痛性骨质疏松脊柱压缩骨折的新型微创技术,能迅速缓解疼痛、改善功能并恢复脊柱序列。     

球囊扩张椎体后凸成形术治疗骨质疏松性椎体压缩骨折

目的:探讨球囊扩张椎体后凸成形术治疗骨质疏松性压缩骨折的疗效和安全性.方法:2006年6月至2009年8月采用球囊扩张椎体后凸成形术治疗26例骨质疏松性椎体压缩骨折,男10例,女16例;年龄59～78岁,平均70岁.T114椎、T1210椎、L112椎、L23椎、L41椎.观察椎体高度恢复、患者疼痛视觉模拟评分及并发症情况.结果:本组26例术后疼痛均得到有效控制,VAS评分由术前的平均(8.6±0.2)分下降为(2.0±0.3)分;手术前后椎体前缘高度分别为(18.34±3.25) mm和(20.51±1.34) mm(P＜0.05),中线高度分别为(14.36±2.56) mm和(19.66±1.28) mm(P＜0.05).未发生骨水泥渗漏到椎管现象.结论:球囊扩张椎体后凸成形术治疗骨质疏松性压缩骨折可有效恢复椎体的高度,缓解疼痛,改善患者的脊柱功能.     

球囊扩张椎体后凸成形术治疗多节段骨质疏松性胸腰椎压缩骨折

目的探讨应用球囊扩张椎体后凸成形术（PKP）治疗多节段老年骨质疏松性脊柱骨折的疗效和安全性。方法自2005年1月至2007年10月,采用球囊扩张椎体后凸成形术治疗骨质疏松性椎体压缩性骨折28例67个病椎,均经单侧椎弓根置入可扩张球囊使骨折塌陷椎体复位,然后使用骨水泥充填椎体,观察术后症状改善及骨折复位情况。结果28例手术均顺利,疼痛于术后24h内均明显缓解,术后无脊髓神经根受损表现,X射线片复查,显示病椎高度明显恢复,后凸畸形大部分矫正。结论经皮球囊扩张椎体后凸成形术治疗多节段性老年骨质疏松脊柱骨折安全有效。     

经皮椎体后凸成形术治疗骨质疏松性椎体压缩性骨折

目的评价球囊扩张椎体后凸成形术治疗老年骨质疏松椎体压缩性骨折的疗效和安全性。方法自2008年8月至2011年7月采用椎体后凸成形术治疗老年骨质疏松脊柱压缩骨折30例42椎,患者均有腰背部疼痛。取俯卧位调节手术床使椎体骨折部位过伸,达到满意的闭合复位后,经皮双侧或单侧椎弓根穿刺球囊扩张,填充骨水泥。随访观察患者的疼痛、日常功能以及影像学改变情况。根据术前和术后侧位X线片测量椎体高度、后凸畸形角度,进行统计学分析。利用Oswestry评分、视觉模拟评分（visualanaloguescale,VAS）评定临床疗效。观察有无骨水泥渗漏等并发症。结果术后随访6～24个月,平均10个月。术后伤椎处疼痛均明显缓解,VAS评分从术前平均（8．45±0．48）分降至术后平均（2．45±0．52）分,椎体高度明显恢复,后凸畸形得到矫正。随访期间疗效满意,伤椎高度无明显丢失。未出现严重的骨水泥渗漏并发症。术后椎体高度及伤椎后凸角度与术前比较有统计学差异（P〈0．05）,术后VAS及Oswestry评分与术前比较有统计学差异（P〈0．01）。结论球囊扩张椎体后凸成形术治疗骨质疏松脊柱压缩性骨折,能有效恢复椎体高度和矫正后凸畸形,能迅速缓解疼痛,减少骨折并发症,提高患者生活质量。     

单侧穿刺PKP术治疗骨质疏松椎体压缩性骨折

目的评价单侧经皮球囊扩张椎体后凸成形术治疗老年骨质疏松性椎体压缩骨折的临床疗效。方法自2010年1月至2013年1月采用单侧经皮球囊扩张椎体后凸成形术治疗老年骨质疏松性椎体压缩骨折60例86椎,其中男18例,女42例;年龄58~83岁,平均68.5岁。均为新鲜骨折,均有明显腰背部疼痛不适,无脊髓、神经根受损症状和体征。术前CT显示椎体后壁完整。MRI显示伤椎在T1WI呈低信号,T2WI呈高信号。经皮单侧椎弓根穿刺球囊扩张,填充骨水泥。测量术前、术后正侧位X线片椎体高度及后凸畸形角度,并进行统计学分析,随访观察患者术前、术后腰背疼痛、日常功能等改变情况。采用视觉模拟评分(visual analogue scale,VAS)、Oswestry评分评定临床疗效。结果术后随访6~24个月,平均14个月。术后腰背部疼痛迅速缓解,随访期间疗效满意,椎体高度明显恢复,后凸畸形得以改善,伤椎高度无明显丢失。7例术后再发其他椎体压缩性骨折再次入院行球囊扩张椎体后凸成形术后得以改善,术后椎体高度及后凸角度与术前相比有统计学差异(P0.05,P0.01),术后VAS评分及Oswestry评分与术前相比差异有统计学意义(P0.01)。结论单侧经皮球囊扩张椎体后凸成形术治疗骨质疏松性椎体压缩骨折,可有效恢复椎体高度和矫正后凸畸形,迅速缓解疼痛,提高生活质量,临床疗效满意。     

球囊单侧扩张椎体后凸成形术治疗老年骨质疏松性椎体压缩骨折

目的探讨球囊单侧扩张椎体后凸成形术治疗老年骨质疏松性椎体压缩骨折的疗效和安全性.方法2004年12月～2006年12月采用球囊单侧扩张椎体后凸成形术治疗30例骨质疏松性椎体压缩骨折患者,共44个伤椎,其中男13例19个伤椎,女17例25个伤椎;年龄66～83岁,平均72岁;骨折部位为T7～L5椎体,术前CT显示椎体后壁均完整.结果30例患者均手术顺利,3例3个椎体前缘有少许未引起临床症状的骨水泥渗漏,其余椎体X线片上均未见明显骨水泥渗漏.所有患者术后48h内疼痛明显减轻或消失并可下床活动,住院4～12 d.随访6～24个月,平均14个月,术前平均疼痛视觉模拟评分(VAS)为8.6±0.2分,术后为2.0±0.3分,末次随访时为2.1±0.2分,术后评分显著低于术前(P＜0.01);Oswestry功能评分由术前43.1±1.1分降低到术后20.3±1.2分和末次随访21.1±1.2分(P＜0.01);伤椎前、中柱的平均高度由术前15.1±1.8mm增加到术后24.3±2.1 mm和末次随访24.4±1.8 mm,手术前后差异有显著性(P＜0.05).脊柱后凸Cobb角由术前平均21.2°±4.3°减小到术后10.1°±3.2°和末次随访10.2°±3.3°(P＜0.05).结论球囊单侧扩张椎体后凸成形术可有效恢复骨质疏松性椎体压缩骨折椎体的高度,缓解疼痛,改善患者的脊柱功能及减少骨水泥渗漏,临床疗效满意.     

球囊扩张椎体成形术联合降钙素治疗老年骨质疏松性椎体骨折的疗效

目的回顾性分析球囊扩张椎体后凸成形术联合降钙素治疗骨质疏松性椎体骨折的疗效。方法 2007年2月～2010年1月,对25例35个椎体发生骨质疏松性椎体骨折患者行球囊扩张椎体后凸成形术联合降钙素综合治疗。术中在透视机监视下采用单侧椎弓根穿刺,置入1枚可扩张球囊使骨折塌陷椎体复位,灌注骨水泥充填由球囊扩张所形成的椎体内空腔。术后每天静脉注射鲑鱼降钙素,通过观察患者术后症状改善及骨折复位情况来评估其疗效。结果所有患者随访6～32个月,平均（21.3±0.2）个月。全部患者均顺利完成手术,无症状性并发症发生。术后疼痛明显减轻或消失。术后椎体高度平均恢复率59.5%。结论球囊扩张椎体后凸成形术治疗骨质疏松性椎体骨折可有效缓解疼痛、改善功能及恢复脊柱序列,联合降钙素的应用能有效缓解骨质疏松性椎体压缩骨折引起的疼痛,是治疗骨质疏松性椎体骨折的较好微创方法之一。     

椎体后凸成形术治疗多发性老年骨质疏松脊柱骨折

目的 探讨应用球囊扩张椎体后凸成形术(Kyphoplasty)治疗多发性老年骨质疏松性脊柱骨折的疗效和安全性。方法 治疗8例17椎多发性老年骨质疏松性脊柱骨折,患者均不伴神经损伤,术前X线及MRI检查证实多发性脊柱骨折,手术在C型臂X线机透视下进行,经皮穿刺,置入可扩张球囊于伤椎塌陷终板前下方,扩张球囊提升终板以恢复椎体高度,在持续X线监视下注入骨水泥强化椎体,同法完成各伤椎的操作。结果 8例17椎均顺利完成手术,术后无脊髓神经根受损表现,48h内疼痛均缓解。X线片复查示伤椎高度基本恢复,后凸畸形大部矫正,未发现并发症。结论 球囊扩张椎体后凸成形术治疗多发性老年骨质疏松脊柱骨折安全有效。     

Is the recovery profile of mivacurium independent of the rate of decay of its plasma concentration in patients with normal plasma cholinesterase activity?

Background: The duration of action of muscle relaxants is poorly correlated to the rate of decay of their plasma concentration. The plasma concentration of mivacurium may rapidly decrease below its active concentration because of the extensive hydrolysis of mivacurium. By inflating a tourniquet on one upper limb for 3 min after the administration of atracurium, mivacurium or vecuronium, we studied the influence of the initial decline of their plasma concentration on their effect. Methods: In 50 patients anaesthetised with thiopental, isoflurane and fentanyl, the effect of bolus doses of 0.15 or 0.25 mg . kg^?1 mivacurium (MIV 15, MIV 25), 0.3 or 0.5 mg . kg^?1 atracurium (ATR 30, ATR 50) and 0.06 or 0.1 mg . kg^?1 vecuronium (VEC 06, VEC 10) were measured on both arms (evoked response of the adductor pollicis to train-of-four stimulation every 12 s), a tourniquet being applied on one arm just before and during 3 min after the muscle relaxant bolus. Results: Tourniquet inflation of 3 min almost abolished the neuromuscular effect of mivacurium. In the vecuronium groups and in the ATR 50 group, tourniquet inflation did not modify the maximum degree of depression of the twitch response. Also, the duration of action of vecuronium was unaffected by the tourniquet. In the ATR 30 group, times to return of the twitch response to 25% (duration 25%) and 75% (duration 75%) of control response were significantly shorter in the cuffed arm, 23 min vs 27 min, and 41 min vs 45 min, respectively. In the ATR 50 group, only duration 25% was significantly shorter in the cuffed arm (41 min vs 45 min). Conclusion: The results suggest that the rate of decline of the plasma concentration of mivacurium is so rapid, that a very low and almost clinically ineffective concentration is present as soon as 3 min after its administration. The results also indicate that the recovery from a mivacurium-induced neuromuscular blockade is not influenced by the rate of decay of its plasma concentration in patients with genotypically normal plasma cholinesterase.     

Membranes in Artificial Organs

Abstract: Membrane processes play a pivotal and enabling role in modern replacement therapy for acute and chronic organ failure and in the management of immunologic diseases. In fact, virtually all contemporary extracorporeal blood purification methods employ membrane devices, and the next generation of artificial organs and tissue engineering therapies are almost certain to be similarly grounded in membrane technology. In this short essay, we comment on the similarities and differences among synthetic membranes and their natural counterparts and also provide a critical overview of the demographics and technology of hemodialysis, hemofiltration, apheresis, oxygenation, and emerging membrane technologies and applications.     

Reduction of Plasma Fibrinogen, Immunoglobulin G, and Immunoglobulin M Concentrations by Immunoadsorption Therapy with Tryptophan and Phenylalanine Adsorbents

Abstract Immunoadsorption (1A) therapy with tryptophan (TR-350) or phenylalanine (PH-350) adsorbents has been used to reduce the concentration of serum antibodies in human lymphocyte antigen (HLA)-immunized patients. Other forms of plasma purification have been reported to reduce the level of fibrinogen, which affects the blood properties. In this study we investigated the effects of IA therapy using both adsorbents on plasma fibrinogen and immunoglobulins G and M in 13 patients (8 patients were treated with TR-350, and 5 patients were treated with PH-350). During each session 1 plasma volume (2.8 ± 0.4 L of plasma) was processed through the immunocolumn and then returned to the patient together with the blood cells. Compared with the pretreatment values, the plasma fibrinogen, IgG, and IgM concentrations were significantly reduced after IA therapy (p < 0.01 for TR-350; p < 0.04 for PH-350). There was a positive correlation between the degree of reduction of plasma proteins and the number of IA treatments given. A nonpara-metric test (Wilcoxon's signed-rank test or the Mann-Whitney test) was used for statistical analysis. We conclude from our study that IA therapy effectively lowers the plasma levels of fibrinogen, IgG, and IgM and thus can be considered a valuable alternative to other blood purification methods.     

Dilemma of Membrane Biocompatibility and Reuse

Abstract: Numerous articles have been published on the multiple use of dialyzers and on the effect of different reprocessing chemicals and techniques on the dialyzer biocompatibility and performance. The results often appear contradictory, especially those comparing standard biocompatibility parameters. Despite this confusion, a discerning review of the published works allows certain limited conclusions to be drawn. Reprocessing of used hemodialyzers changes the biocompatibility profile of a dialyzer as defined by the parameters complement activation. leukopenia, and cytokine release. The effect of reprocessing depends on the chemicals and reprocessing technique applied and also on the type of membrane polymer being subjected to the reprocessing procedure. Reports of pyrogenic reactions indicate that the flux of the membrane also influences how suitable it is for safe reuse. An increased risk of allergic and pyrogenic reactions appears to be associated with dialyzer reuse. Furthermore, there has been a lack of investigations into the immunologic effect of the layer of adsorbed and chemically altered proteins that remains on the inner surface of reprocessed dialyzers. We conclude that the clinical benefit of dialyzer reuse cannot be generally accepted from a biocompatibility point of view.     

The analgesic effect of racemic ketamine in patients with chronic ischemic pain due to lower extremity arteriosclerosis obliterans

Background : Ketamine in sub-dissociative doses has been shown to have analgesic and phantom-Limb pain, where conventional treatment has often failed. Chronic ischemic pain due to lower extremity arteriosclerosis obliterans often responds poorly to analgesics, and the pain-generating mechanisms are not well understood.
Methods : Eight patients with rest pain in the lower extremity due to arteriosclerosis obliterans were given sub-dissociative doses of 0.15, 0.30, or 0.45 mg/kg racemic ketamine and morphine 10 mg as a 5-min infusion on four separate days in a cross-over, double-blind, randomised protocol. Plasma levels of (S)- and (R)-ketamine and their nor-metabolites were analysed with an enantioselective high-performance liquid chromatography (HPLC) method. Pain levels were evaluated with a visual analogue scale (VAS).
Results : Individual pain levels were highly variable during and after all the infusions but the pooled pain levels showed a dose-dependent analgesic effect of ketamine with a transient but complete pain relief in all patients at the highest dose (0.45 mg/ kg). Side-effects, mainly disturbed cognition and perception, were pronounced and dose-dependent. Morphine 10 mg had an analgesic peak at 20 min and 5/8 patients had complete pain relief. The remaining 3 patients also had high baseline pain scores, indicating a higher analgesic potency for the 0.30 and 0.45 mg/ kg ketamine doses than for morphine 10 mg.
Conclusion : We have demonstrated a potent dose-dependent analgesic effect of racemic ketamine in clinical ischemic pain. Due to a narrow therapeutic window, this analgesic effect is probably best utilised in combination with other analgesics.     

Intravenous endotoxin does not increase tissue extravasation of albumin in rats

Background : It is unclear whether activation of the inducible nitric oxide synthase (iNOS) increases or decreases the extravasation of plasma.
Methods : Chloralose anaesthetised male Wistar rats received E. coli lipopolysacharide (LPS), 3 mg kg^-1 i.v., or the corresponding volume of saline, 3 or 5 h before the end of the experiment. Mean arterial pressure (MAP) and heart rate (HR) were recorded. Tissue clearance of radio-labelled albumin, during the last 2 h of each experiment, was determined by a double-isotope method. In separate animals, the serum concentration of nitrite and nitrate was determined, 5 h after LPS or the solvent.
Main Results : LPS initially decreased MAP and lastingly increased HR. In the 3-h LPS animals (n=8), tissue plasma clearance was lower in the heart and calf muscle and increased only in diaphragm, compared to corresponding control animals (n=8). In the 5-h LPS rats, clearance was lowered (n=8) in the entire gastrointestinal tract and in testes, compared to controls (n=8). The serum nitrite/nitrate concentration was higher in animals given LPS (n=6) than in controls (n=6).
Conclusion : After LPS, tissue clearance of albumin was not increased in any major tissue, in spite of increased serum levels of NO end products. Apparently, after activation of iNOS, the augmented release of NO is not necessarily associated with increased albumin extravasation.     

The multiply injured child

Blunt trauma is the principal cause of childhood death in many developed countries. This review outlines the differences between adults and children with respect to resuscitation and treatment of orthopaedic injuries in a child with polytrauma. Recent advances in techniques of fracture stabilization are reported.     

Adrenaline markedly improves thoracic epidural analgesia produced by a low-dose infusion of bupivacaine, fentanyl and adrenaline after major surgery: A randomised, double-blind, cross-over study with and without adrenaline

Background: Basic pharmacological research indicates that there are synergistic antinociceptive effects at the spinal cord level between adrenaline, fentanyl and bupivacaine. Our clinical experience with such a mixture in a thoracic epidural infusion after major surgery confirms this. The objectives of the present study were to evaluate the effects on postoperative pain intensity, pain relief and side effects when removing adrenaline from this triple epidural mixture. Methods: A prospective, randomised, double-blind, cross-over study was carried out in 24 patients after major thoracic or abdominal surgery. Patients with only mild pain when coughing during a titrated thoracic epidural infusion of about 10 ml · h^?1 of bupivacaine 1 mg · ml^?1, fentanyl 2 μg · ml^?1, and adrenaline 2 μg · ml^?1 were included. On the 1^st and 2^nd postoperative days each patient was given a double-blind epidural infusion, at the same rate, with or without adrenaline. The effect was observed for 4 h or until pain when coughing became unacceptable in spite of a rescue analgesic procedure. Rescue analgesia consisted of up to two epidural bolus injections per hour and i.v. morphine if necessary. All patients received rectal paracetamol 1 g, every 8 h. Fentanyl serum concentrations were measured with a radioimmunoassay technique at the start and end of each study period. Main outcome measures were extent of sensory blockade and pain intensity at rest and when coughing, evaluated by a visual analogue scale, a verbal categorical rating scale, the Prince Henry Hospital pain score, and an overall quality of pain relief score. Results: The number of hypaesthetic dermatomal segments decreased (P <0.001) and pain intensity at rest and when coughing increased (P <0.001) when adrenaline was omitted from the triple epidural mixture. This change started within the first hour after removing adrenaline. After 3 h pain intensity when coughing had increased to unacceptable levels in spite of rescue analgesia (epidural bolus injections and i.v. morphine). Within 15–20 min after restarting the triple epidural mixture with adrenaline, pain intensity was again reduced to mild pain when coughing. Serum concentration of fentanyl doubled from 0.22 to 0.45 ng · ml^?1 (P <0.01), and there was more sedation during the period without adrenaline. Conclusions: Adrenaline increases sensory block and improves the pain-relieving effect of a mixture of bupivacaine and fentanyl infused epidurally at a thoracic level after major thoracic or abdominal surgery. Serum fentanyl concentrations doubled and sedation increased when adrenaline was removed from the epidural infusion, indicating more rapid vascular absorption and systemic effects of fentanyl.     

Utilisation des médicaments prokinétiques en réanimation : indications et limites ?

Enteral feeding is often limited by gastric and intestinal motility disturbances in critically ill patients, particularly in patients with shock. So, promotility agents are frequently used to improve tolerance to enteral nutrition. This review summaries the pathophysiology, presents the available pharmacological strategies, the clinical data, the counter-indications and the principal limits. The clinical data are poor. No study demonstrates a positive effect on clinical outcomes. Metoclopramide and erythromycin seems to be the more effective. Considering the risk of antibiotic resistance, the first line use of erythromycin should be avoided in favor of metoclopramide.